A total of 23 case-control studies matched the inclusion criteria [10, 13-25, 27-30, 49, 53, 54, 73, 74], including one that discussed the relationship between mTOR polymorphisms and meningioma [28], which is generally considered to be benign. This evidence concerns the gene MTOR and meningioma.